Patent Assignment
Reel/Frame 037690/0466
Change of Name
Recorded: 2016-02-03
Pages: 5
Assignor
THREE RIVERS PHARMACEUTICALS, LLC
Executed: 2011-07-05
Assignee
KADMON PHARMACEUTICALS, LLC
119 COMMONWEALTH DRIVE, WARRENDALE, PENNSYLVANIA, 15086
Covered Property
(1)
Large Dose Ribavirin Formulations
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Jun 25, 2013
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030678/0620 →
Security Agreement
Jun 25, 2013
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030678/0514 →
Release of Security Interest
Aug 31, 2015
From: MACQUARIE US TRADING LLC
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 036461/0825 →
Security Interest
Aug 31, 2015
From: KADMON PHARMACEUTICALS, LLC
To: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
Reel/Frame 036460/0811 →
Security Interest
Sep 2, 2015
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 036478/0611 →
Termination of Patent and Trademark Security Agreement
Nov 25, 2019
From: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 051106/0789 →
Assignment of Assignor's Interest
Jul 26, 2022
From: KADMON PHARMACEUTICALS, LLC
To: CHARTWELL PHARMACEUTICALS LLC
Reel/Frame 060622/0317 →